CLINICAL_TRIALS
trial_result
· 2026-03-10
Clinical Trial Update: Myasthenia Gravis Inebilizumab Trial [Phase 3]
Summary
Phase 3 trial update of inebilizumab for myasthenia gravis has posted results; the study is active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Myasthenia Gravis | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-03-10